OLIGORIBONUCLEOTIDE DERIVATIVES FOR THE TARGETED INHIBITION OF GENE EXPRESSION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, METHOD FOR THEIR PREPARATION AND USE THEREOF
The present invention relates to oligoribonucleotide derivatives which have a 2'5'-linked oligoribonucleotide residue without a 5'-phosphate residue on the 3' end and to the use thereof for specific inhibition of gene expression.
